GKResearcher profile · from public sources
Guido Kroemer
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma.
Oncoimmunology, Sept 2026
Publication
Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.
Journal for immunotherapy of cancer, Jun 2026
Publication
Spermine is an endogenous iron chelator that inhibits ferroptosis.
Nature, Jun 2026
Publication
Pro-aging effects of chronic glucocorticoid signaling.
Cell metabolism, May 2026
Publication
Exercise-induced changes in physical performance and circulating acyl-CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in older adults with and without HIV.
The journals of gerontology. Series A, Biological sciences and medical sciences, May 2026
Publication
The autophagy-inhibitory tissue hormone DBI/ACBP is essential for glucocorticoid-induced immunosuppression.
Autophagy, May 2026
Publication
Neutralization of DBI/ACBP for the prevention of ciliopathy-associated obesity.
Autophagy, Mar 2026
Publication
KRAS-elicited PDIA6 blocks PERK-dependent immunogenic cell death in pancreatic carcinoma.
Oncoimmunology, Mar 2026
Publication
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance.
Proceedings of the National Academy of Sciences of the United States of America, Mar 2026
Publication
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Nature medicine, Jan 2026
Publication
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
Nature medicine, Jan 2026
Publication
Identification of ACBP as a potential target in ciliopathic obesity through multi-omics network analysis.
Nature communications, Jan 2026
Publication
Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.
Journal of translational medicine, Dec 2025
Publication
Targeting PRDX6-dependent localization and function of GPX4 enhances ferroptosis-mediated tumor suppression.
Molecular cell, Dec 2025
Publication
ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases.
Cell death & disease, Nov 2025
Publication
Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease.
Molecular cancer, Nov 2025
Publication
FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer.
Oncoimmunology, Nov 2025
Preprint
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Research square, Oct 2025
Publication
The autophagy-recessive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) contributes to the pathogenesis of osteoarthritis.
Autophagy, Oct 2025
Publication
Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination Strategy.
Cancers, Jan 2025
Publication
SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition.
Science advances, Dec 2024
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Laurence Zitvogel directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error